Medtronic (MDT) call put ratio 1.4 calls to 1 put into quarter results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- Wall Street rallies as AI optimism reignites and Treasury yields retreat
Needham on Medtronic, Inc. (MDT): 'We believe that MDT is in the early stages of a strong product cycle'
September 1, 2026 1:27 PM EDTNeedham analyst Michael Matson reiterated a Buy rating and $114.00 price target on Medtronic, Inc. (NYSE: MDT).
The analyst comments "MDT's F1Q27 revenue and EPS beat consensus, and management raised FY27 revenue and EPS guidance. Organic growth improved to 7.0%... More
